Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Zactima’s FDA Application withdrawn (NASDAQ:AZN)
favstocks.com
Sunday, January 31, 2010 - 11:19am
tags:
Zactima, AstraZeneca, non-small cell lung cancer, lung cancer
Keryx Biopharmaceuticals Announces Positive Phase 2 Study Results Of Perifosine As A Single Agent For The Treatment Of Waldenstrom's Macroglobulinemia
Medical News Today
Saturday, January 30, 2010 - 12:14pm
tags:
Keryx, Waldenstrom's Macroglobulinemia
FDA wants drug companies to look at potential for abuse
physorg.com
Saturday, January 30, 2010 - 12:13pm
tags:
FDA
Sun Pharma suffers setback, consolidated net dips by 17% in Q3
Pharmabiz
Saturday, January 30, 2010 - 12:12pm
tags:
Sun Pharma
Watson Pharmaceuticals Closes Acquisition of Eden Biodesign for Approximately $15 Million
Trans World News
Saturday, January 30, 2010 - 12:05pm
tags:
Watson Pharmaceuticals
Sanofi-aventis signs pact with Minsheng Pharma to establish new consumer healthcare JV in China
Pharmabiz
Saturday, January 30, 2010 - 12:00pm
tags:
Sanofi, Minsheng Pharma, China
GSK's TYKERB(R) Receives Accelerated Approval for First-Line Combination Treatment of Metastatic Breast Cancer
Yahoo/PR NewsWire
Saturday, January 30, 2010 - 11:56am
tags:
GSK, Tykerb, breast cancer
FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures
Yahoo/PR NewsWire
Saturday, January 30, 2010 - 11:54am
tags:
GSK, Lamictal, epilepsy
With Their Rights Squabble Settled, Eli Lilly and Bristol-Myers Squibb Look Ahead
Seeking Alpha
Saturday, January 30, 2010 - 11:52am
tags:
Eli Lilly, Bristol-Myers Squibb
How to Make Billions of Dollars Without Really Trying
Motley Fool
Saturday, January 30, 2010 - 11:51am
tags:
Alzheimer's disease
Flexion lands $42M, acquires drug targets
bizjournals
Saturday, January 30, 2010 - 11:12am
tags:
Flexion, Pfizer, AstraZeneca, Merck Serono
All Grown Up, With Cash to Burn (BMS)
Motley Fool
Saturday, January 30, 2010 - 11:11am
tags:
Bristol-Myers Squibb
Pivotal Trial Results for Motavizumab Published in Current Issue of 'Pediatrics'
Yahoo/PR NewsWire
Saturday, January 30, 2010 - 11:10am
tags:
MedImmune, motavizumab, RSV
AstraZeneca, Eli Lilly Foreboding for Sector
Minyanville
Saturday, January 30, 2010 - 11:08am
tags:
AstraZeneca, Eli Lilly
SurModics Beats
Yahoo/Zacks
Saturday, January 30, 2010 - 11:06am
tags:
SurModics
Enzon Completes Sale of Specialty Pharmaceutical Business
Yahoo/BusinessWire
Saturday, January 30, 2010 - 11:04am
tags:
Enzon
SQNM Jumps 3% As BlackRock Takes 6% Stake
Barron's
Saturday, January 30, 2010 - 11:03am
tags:
Sequenom
Wake Up! You Still Have to Pay Attention (Celgene)
Motley Fool
Saturday, January 30, 2010 - 11:02am
tags:
Celgene
Immunogen drops guidance after tough Q2
bizjournals
Saturday, January 30, 2010 - 10:52am
tags:
Immunogen
Celgene Beats Zacks Estimate
Zacks
Saturday, January 30, 2010 - 10:48am
tags:
Celgene

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.